Article
Genetic variation in CYB5R3 is associated with methemoglobin levels in preterm infants receiving nitric oxide therapy.
Pediatric research - 1 Mar 2015
Fuller Tyson D, Spracklen Cassandra N, Ryckman Kelli K, Knake Lindsey A, Busch Tamara D, Momany Allison M, Murray Jeffrey C, Dagle John M
Abstract excerpt
BACKGROUND: In recent years, increasing numbers of preterm infants have been exposed to inhaled nitric oxide (iNO). This population has decreased methemoglobin (MetHb) reductase activity in their erythrocytes, which may increase the risk of MetHb toxicity. We sought to determine if genetic factors are associated with the observed variance in MetHb levels. METHODS: A population of 127 preterm infants was genotyped...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
